Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLuceco Plc Regulatory News (LUCE)

Share Price Information for Luceco Plc (LUCE)

Share Price is delayed by 15 minutes
Get Live Data
266.00    -1.00 (-0.37%)
Bid:
265.00
Ask:
267.00
Spread: 2.00 (0.755%)
Market Cap: £391.53m
LUCE Live PriceLast checked at - London Stock Exchange

Intraday Luceco Plc Share Chart

2024 Full Year Trading Update

23 Jan 2025 07:00

RNS Number : 3620U
Luceco PLC
23 January 2025
 

23 January 2025

 

LUCECO PLC - 2024 FULL YEAR TRADING UPDATE

 

 

Results ahead of expectations, strong demand in the final quarter.

Well positioned for further growth in 2025

 

Luceco plc ("Luceco" or the "Group"), the supplier of wiring accessories, EV chargers, LED lighting and portable power products, is pleased to provide the following update on trading for the year ended 31 December 2024 ("2024").

 

 

Q4 2024 Trading

 

· The improving trend in order intake experienced in Q3 accelerated through the final quarter of the year with strong demand driving organic growth.

· The strong order book from Q3, combined with increased trade and retail orders, led to impressive sales growth at the end of the year in the Group's Residential RMI divisions.

· Our Residential EV Charger division also continued to outperform, with quarterly year-on-year growth of c.50%, reflecting both a strengthening market and successful new product launches.

 

 

2024 Full Year Results

· The Group expects to report a full year 2024 performance ahead of market expectations*, with revenue in the region of £240m (2023: £209m) and Adjusted Operating Profit in the region of £28.5m - £29.0m (2023: £24.0m).

· Further progress on Adjusted Operating Margin for the full year, moving towards c.12.0% (2023: 11.5%) driven by product mix, operating efficiencies and additional volume.

· Despite challenging economic conditions our brands have performed strongly, delivering Group organic growth of c.5% for the year (at constant currencies).

· Both businesses that we acquired in 2024 are integrating well, with the contribution from D-Line (acquired in February 2024) especially encouraging. We are pleased with the progress made to date to realise cost synergies from D-Line and with the early indications from CMD.

· The Group's balance sheet remains robust with Bank Net Debt at 1.7x EBITDA (within our target range of 1.0 - 2.0x) despite increased working capital requirements commensurate to the strong trading in Q4.

 

 

Commenting on the trading update, Chief Executive Officer, John Hornby said:

 

"Luceco performed well in 2024, finishing the year strongly against the backdrop of a lacklustre macroeconomic environment in the UK. As a result, we anticipate reporting Adjusted Operating Profit ahead of market expectations. We look forward to further growth in 2025, hopeful of improved end-market demand, but confident that the Group is well positioned to make solid progress against its strategic objectives."

 

 

*Company compiled analyst consensus as at 22 January 2025 is for full year 2024 revenue of £234.2m (Analyst Range of £232.8m - £234.6m) and Adjusted Operating Profit of £26.5m (Analyst Range £26.0m - £27.2m)

 

 

Luceco plc

Contact

John Hornby, Chief Executive Officer

07817 458804 (Via MHP)

Will Hoy, Chief Financial Officer

MHP

Contact

Tim Rowntree

Ollie Hoare

07817 458804

 

 

For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is being made on behalf of Luceco plc by Will Hoy, Chief Financial Officer.

 

Note to Editors

 

Luceco plc - Bringing Power To Life

 

Luceco plc (LSE:LUCE) is a supplier of wiring accessories, EV chargers, LED lighting, and portable power products.

 

For more information, please visit www.lucecoplc.com.

 

Forward-looking statements

 

This announcement contains forwardlooking statements that are subject to risk factors associated with, among other things, the economic and business circumstances occurring from time to time in the countries, sectors and markets in which the Group operates. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a wide range of variables which could cause actual results to differ materially from those currently anticipated. No assurances can be given that the forwardlooking statements in this announcement will be realised.

 

The forwardlooking statements reflect the knowledge and information available at the date of preparation of this announcement and the Company undertakes no obligation to update these forwardlooking statements. Nothing in this announcement should be construed as a profit forecast.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEAPFAALKSEFA
Date   Source Headline
2nd Jun 20204:16 pmRNSDirector/PDMR Shareholding
27th May 20207:00 amRNSArrangements for 2020 AGM
15th May 20207:00 amRNSAppointment of Senior Independent Director
14th May 202011:30 amRNSHolding(s) in Company
5th May 20204:06 pmRNSAnnual Report and Accounts 2019 & 2020 AGM Notice
4th May 202010:26 amRNSHolding(s) in Company
28th Apr 20205:42 pmRNSDirector/PDMR Shareholding
23rd Apr 20207:00 amRNS2019 Full Year Results
20th Apr 202012:07 pmRNSSecond Price Monitoring Extn
20th Apr 202012:02 pmRNSPrice Monitoring Extension
17th Apr 202012:00 pmRNSBoard changes
17th Apr 20207:00 amRNSNotice of Results
15th Apr 20203:23 pmRNSHolding(s) in Company
14th Apr 202012:07 pmRNSSecond Price Monitoring Extn
14th Apr 202012:02 pmRNSPrice Monitoring Extension
14th Apr 202010:57 amRNSHolding(s) in Company
9th Apr 20204:42 pmRNSSecond Price Monitoring Extn
9th Apr 20204:37 pmRNSPrice Monitoring Extension
25th Mar 202012:08 pmRNSSecond Price Monitoring Extn
25th Mar 202012:03 pmRNSPrice Monitoring Extension
24th Mar 20203:26 pmRNSReporting moratorium and coronavirus impact
16th Mar 20204:42 pmRNSSecond Price Monitoring Extn
16th Mar 20204:37 pmRNSPrice Monitoring Extension
13th Mar 20204:45 pmRNSHolding(s) in Company
13th Mar 20204:45 pmRNSHolding(s) in Company
4th Feb 20203:27 pmRNSDirector/PDMR Shareholding
28th Jan 20207:00 amRNSFull Year Trading Update
24th Jan 20203:43 pmRNSEmployee Benefit Trust Share Purchase
17th Jan 202010:12 amRNSEmployee Benefit Trust Share Purchase
14th Jan 20202:23 pmRNSEmployee Benefit Trust Share Purchase
14th Nov 20197:00 amRNSAppointment of Joint Corporate Broker
1st Oct 20192:19 pmRNSDirector/PDMR Shareholding
13th Sep 201912:05 pmRNSDirector/PDMR Shareholding
13th Sep 201910:15 amRNSDirector/PDMR Shareholding
9th Sep 20197:00 amRNSHalf Year Results
3rd Sep 201910:36 amRNSDirector/PDMR Shareholding
28th Aug 201912:51 pmRNSDirectorate Change
27th Aug 201912:07 pmRNSSecond Price Monitoring Extn
27th Aug 201912:02 pmRNSPrice Monitoring Extension
30th Jul 20197:00 amRNSFirst Half Trading Update
22nd Jul 201912:02 pmRNSPrice Monitoring Extension
11th Jul 20195:04 pmRNSEmployee Benefit Trust Share Purchase
8th Jul 20195:30 pmRNSEmployee Benefit Trust Share Purchase
3rd Jul 20194:23 pmRNSDirector/PDMR Shareholding
2nd Jul 20193:44 pmRNSDirector/PDMR Shareholding
4th Jun 20193:31 pmRNSDirector/PDMR Shareholding
31st May 20199:40 amRNSEmployee Benefit Trust Share Purchase
28th May 201912:59 pmRNSDirector Declaration
24th May 20193:20 pmRNSResult of AGM
24th May 20197:00 amRNSAGM Trading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.